Schrödinger, Inc.

Schrödinger, Inc. is an international company that develops various pharmaceutical products.

Nasdaq: SDGR
Russell 2000 Index component
FounderRichard A. Friesner,
William A. Goddard III
HeadquartersNew York, NY
Area served
Key people
Ramy Farid
(President & CEO)
Michael Lynton
  • Advanced computational platform for drug discovery and materials science
  • LiveDesign
  • PyMOL
Revenue $85.4 Million (2019)[1]
Number of employees

Products and Services

Schrödinger's computational platforms evaluate compounds in silico, with experimental accuracy on properties such as binding affinity and solubility. The company's products include molecular modelling programs, and an Enterprise Informatics Platform named LiveDesign, which is intended to facilitate communication among interdisciplinary research teams.[2]

In addition to computational platforms, Schrödinger develops custom software for enterprises, as well as training, computer-cluster design and implementation, and research-based drug discovery projects.[3][4]


Schrödinger's partners include pharmaceutical companies, including Bayer,[5] Takeda,[6] and more.

Nimbus Therapeutics, co-founded by Schrödinger, uses Schrödinger's drug screening and design platform for drug discovery. In 2016, Nimbus Therapeutics sold an Acetyl-CoA carboxylase (ACC) inhibitor designed by Schrödinger to Gilead in a deal worth up to $1.2 billion.[7] As of spring 2019 the ACC inhibitor was moving through late-stage clinical trials in NASH.[8]


In November 2013, Schrödinger, in collaboration with Cycle Computing and the University of Southern California, set a record for the world's largest and fastest cloud computing run by using 156,000 cores on Amazon Web Services to screen over 205,000 molecules for materials science research.[9] That work was a follow up to a 2012 collaboration which saw Cycle Computing creating a 50,000 core virtual supercomputer using Amazon and Schrödinger's infrastructure, which at that time was used to analyze 2.1 million compounds in 3 hours.[10]


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.